Paper Details

  1. Home
  2. Paper Details

Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects.

Author: AultPatricia S, KaledElizabeth S, Nodzon PhDLisa A, Rose PharmDJohn

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Bosutinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of chronic myeloid leukemia (CML) resistant to or intolerant of other TKIs. While effective, bosutinib can cause side effects, including diarrhea, rash, and liver enzyme elevations. Optimal response to bosutinib requires adherence, which can be facilitated by patient education, timely follow-up, and close monitoring of potential side effects.
Paper Details　
Original Abstract of the Article :
The past decade has witnessed great advances in the treatment of chronic myeloid leukemia (CML), brought about in large part by the development of BCR-ABL tyrosine kinase inhibitors (TKIs). Bosutinib joins the armamentarium of approved TKIs for the treatment of chronic phase (CP), accelerated phase ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.6004/jadpro.2016.7.2.3

データ提供：米国国立医学図書館（NLM）

Bosutinib: Navigating the Side Effects in the Desert of CML

We're journeying into the realm of cancer treatment, specifically looking at bosutinib, a tyrosine kinase inhibitor (TKI) used for chronic myeloid leukemia (CML). This article explores the practical considerations for managing the side effects of bosutinib therapy. Imagine a camel caravan, encountering different types of desert terrain, each presenting unique challenges requiring careful navigation.

Managing the Terrain: Side Effects of Bosutinib

The study highlights the distinct side effect profile of bosutinib, with diarrhea being the most common. It's essential for healthcare providers to be aware of these potential side effects and manage them effectively. This is like a camel guide, equipped with knowledge of different types of desert terrain, able to anticipate and address potential challenges before they arise.

A Collaborative Approach: Patient Education and Monitoring

Effective bosutinib therapy requires a collaborative effort between healthcare providers and patients. Patient education and close monitoring are crucial to ensure proper adherence to treatment and early detection of any potential side effects. It's like a camel caravan working together, with each camel contributing to the overall success of the journey.

Dr. Camel's Conclusion

This study provides a comprehensive overview of bosutinib therapy, emphasizing the importance of understanding and managing its side effects. Just as a camel caravan relies on careful planning and communication to overcome desert challenges, successful cancer treatment involves a collaborative partnership between healthcare professionals and patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-04
Further Info :

Pubmed ID

28090366

DOI: Digital Object Identifier

10.6004/jadpro.2016.7.2.3

Related Literature

Article Analysis
・Side Effects of bosutinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.